Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Adamas Pharmaceuticals, Inc. (ADMS)

« Back to company index

ADMS Chatter Timeline

Stock Ticker for ADMS

Most Active Tweeters for ADMS

No tweets found

Recent Tweets for ADMS

TheMarketsDaily @TheMarketsDaily
Adamas Pharmaceuticals Inc $ADMS Expected to Announce Quarterly Sales of $10.10 Million https://t.co/HyFLt6wTbV
August 21st 2018, 7:08pm
ZolmaxNews @ZolmaxNews
Adamas Pharmaceuticals Inc $ADMS Expected to Post Earnings of -$1.33 Per Share https://t.co/uLX45POjuh
August 21st 2018, 7:08pm
dakotafinancial @dakotafinancial
Brokerages Anticipate Adamas Pharmaceuticals Inc $ADMS Will Post Earnings of -$1.33 Per Share https://t.co/lzF1cpK8uV
August 21st 2018, 6:08pm
registrarjourn @registrarjourn
Adamas Pharmaceuticals Inc $ADMS Stake Lessened by Dupont Capital Management Corp https://t.co/eQFZ5zoSbl
August 21st 2018, 6:08pm
EnterpriseLeade @EnterpriseLeade
Adamas Pharmaceuticals Inc $ADMS Stake Lessened by Dupont Capital Management Corp https://t.co/EfHFoZ0tWE
August 21st 2018, 6:08pm
The_CasualSmart @The_CasualSmart
As Adamas Pharmaceuticals $ADMS Shares Rose, Ardsley Advisory Partners Upped Its Holding by $1.50 Million; Busey Tr… https://t.co/vdT4DlCyDZ
August 21st 2018, 2:08pm
usindexlive @usindexlive
As Adamas Pharmaceuticals Com $ADMS Valuation Rose, Bainco International Investors Increased Position by $1.24 Mill… https://t.co/i60L0RPKjO
August 21st 2018, 12:08pm
WatchlistN @WatchlistN
Adamas Pharmaceuticals $ADMS Rating Reiterated by Mizuho https://t.co/b0KJGX81fl
August 21st 2018, 7:08am
The_CasualSmart @The_CasualSmart
Adamas Pharmaceuticals $ADMS Holder Emerald Advisers Upped Its Holding by $1.91 Million; Lipe & Dalton Has Trimmed… https://t.co/CosRpH3Vxh
August 20th 2018, 11:08am
usindexlive @usindexlive
Adamas Pharmaceuticals $ADMS Shareholder Kerrisdale Advisers Boosted Holding; Verint Systems $VRNT Shareholder Riv… https://t.co/gEFivr21o6
August 20th 2018, 8:08am
TheMarketsDaily @TheMarketsDaily
Mizuho Reiterates Buy Rating for Adamas Pharmaceuticals $ADMS https://t.co/2tL7qc5Riv
August 20th 2018, 2:08am
bbnsnews @bbnsnews
Adamas Pharmaceuticals Inc $ADMS Expected to Announce Earnings of -$1.33 Per Share https://t.co/UVhngMi3fp
August 19th 2018, 7:08am
dakotafinancial @dakotafinancial
Adamas Pharmaceuticals’ $ADMS “Buy” Rating Reaffirmed at Mizuho https://t.co/D889v0VjWw
August 19th 2018, 5:08am
TickerReport @TickerReport
Adamas Pharmaceuticals $ADMS Stock Rating Reaffirmed by Mizuho https://t.co/im5zLG5MTn
August 19th 2018, 5:08am
ConsumerFeed @ConsumerFeed
Adamas Pharmaceuticals $ADMS Given “Buy” Rating at Mizuho https://t.co/9minp2AKpp
August 18th 2018, 12:08pm
registrarjourn @registrarjourn
Adamas Pharmaceuticals Inc $ADMS Receives $42.63 Average PT from Analysts https://t.co/9WpktFIQfL
August 18th 2018, 12:08pm
dispatchtribune @dispatchtribune
$10.10 Million in Sales Expected for Adamas Pharmaceuticals Inc $ADMS This Quarter https://t.co/0zGbZhwkT2
August 18th 2018, 1:08am
AmericanBanking @AmericanBanking
$10.10 Million in Sales Expected for Adamas Pharmaceuticals Inc $ADMS This Quarter https://t.co/j93ko4sqzl #stocks
August 18th 2018, 1:08am
OlympiaReport @OlympiaReport
$10.10 Million in Sales Expected for Adamas Pharmaceuticals Inc $ADMS This Quarter https://t.co/SgHE5JjTqb
August 18th 2018, 1:08am
TV_TradingIdeas @TV_TradingIdeas
ADMS 100% or 1+ % a day PROFIT $ADMS https://t.co/eq9NAmMlks
August 17th 2018, 9:08pm
pisciotta @pisciotta
Unusual #Option Activity: Adamas Pharmaceuticals $ADMS The 30 strike puts traded 1,000 contracts for the weeklies… https://t.co/YnssMAbqH3
August 17th 2018, 6:08pm
ZolmaxNews @ZolmaxNews
Mizuho Reiterates “Buy” Rating for Adamas Pharmaceuticals $ADMS https://t.co/2eC7y7DnaE
August 17th 2018, 6:08pm
dailypoliticaln @dailypoliticaln
Mizuho Reiterates “Buy” Rating for Adamas Pharmaceuticals $ADMS https://t.co/kJgdJNQn5O
August 17th 2018, 6:08pm
AmericanBanking @AmericanBanking
Adamas Pharmaceuticals $ADMS Rating Reiterated by Mizuho https://t.co/icGJ9xPm7M #stocks
August 17th 2018, 6:08pm
WatchlistN @WatchlistN
Adamas Pharmaceuticals $ADMS Trading Down 5.2% https://t.co/dwsr01Is83
August 17th 2018, 9:08am
TickerReport @TickerReport
Adamas Pharmaceuticals $ADMS Stock Price Down 5.2% https://t.co/JESACbu45l
August 17th 2018, 9:08am
registrarjourn @registrarjourn
Adamas Pharmaceuticals Inc $ADMS Short Interest Update https://t.co/pU5BiN4rVN
August 17th 2018, 6:08am
AmericanBanking @AmericanBanking
Adamas Pharmaceuticals Inc $ADMS Expected to Announce Earnings of -$1.33 Per Share https://t.co/0wEXMmDTAW #stocks
August 17th 2018, 12:08am
TranscriptDaily @TranscriptDaily
Adamas Pharmaceuticals Inc $ADMS Sees Significant Decline in Short Interest https://t.co/EMzgTwjLAC
August 16th 2018, 1:08am
ZolmaxNews @ZolmaxNews
Adamas Pharmaceuticals Inc $ADMS Receives $42.63 Consensus PT from Analysts https://t.co/p03oIoghwD
August 16th 2018, 12:08am
dailypoliticaln @dailypoliticaln
Adamas Pharmaceuticals Inc $ADMS Receives Consensus Rating of “Buy” from Analysts https://t.co/yHdGxM73YZ
August 16th 2018, 12:08am
ZolmaxNews @ZolmaxNews
Adamas Pharmaceuticals $ADMS Shares Down 5.2% https://t.co/NbMHJaQpHd
August 15th 2018, 7:08pm
registrarjourn @registrarjourn
Somewhat Favorable News Coverage Somewhat Unlikely to Affect Adamas Pharmaceuticals $ADMS Stock Price https://t.co/A8UBdOmC0K
August 15th 2018, 11:08am
EnterpriseLeade @EnterpriseLeade
Somewhat Favorable News Coverage Somewhat Unlikely to Affect Adamas Pharmaceuticals $ADMS Stock Price https://t.co/vLAvLGJgA5
August 15th 2018, 11:08am
AmericanBanking @AmericanBanking
Adamas Pharmaceuticals Inc $ADMS Sees Significant Decline in Short Interest https://t.co/sORCgA1v8c #stocks
August 15th 2018, 10:08am
WatchlistN @WatchlistN
Adamas Pharmaceuticals Inc $ADMS Sees Significant Decline in Short Interest https://t.co/1SMRAaw3NW
August 15th 2018, 10:08am
MareaInformativ @MareaInformativ
Analyzing MannKind $MNKD and Adamas Pharmaceuticals $ADMS https://t.co/Zq5E9xqFn6
August 15th 2018, 12:08am
MareaInformativ @MareaInformativ
Adamas Pharmaceuticals $ADMS PT Set at $45.00 by HC Wainwright https://t.co/p3a73jARJM
August 14th 2018, 12:08pm
usindexlive @usindexlive
Adamas Pharmaceuticals Com $ADMS Stake Has Upped by Bainco International Investors; Wharton Business Group Has Boos… https://t.co/0iNRxYm2dH
August 14th 2018, 5:08am
registrarjourn @registrarjourn
Dupont Capital Management Corp Has $2.17 Million Stake in Adamas Pharmaceuticals Inc $ADMS https://t.co/eQFZ5zoSbl
August 13th 2018, 8:08pm
OlympiaReport @OlympiaReport
Brokerages Set Adamas Pharmaceuticals Inc $ADMS Price Target at $42.63 https://t.co/l3DAKODY6p
August 13th 2018, 2:08pm
dispatchtribune @dispatchtribune
Adamas Pharmaceuticals Inc $ADMS Given Average Recommendation of “Buy” by Analysts https://t.co/db15EbNa1T
August 13th 2018, 2:08pm
beyond_ninety @beyond_ninety
Rhenman & Partners Asset Management Ab Has Lowered Position in Adamas Pharmaceuticals $ADMS as Share Price Rose; Ca… https://t.co/uDe2mY4xRD
August 13th 2018, 5:08am
ThisLincolnian @ThisLincolnian
Adamas Pharmaceuticals $ADMS Upgraded to Sell by BidaskClub https://t.co/70UZwTh164
August 13th 2018, 1:08am
ConsumerFeed @ConsumerFeed
Adamas Pharmaceuticals $ADMS Upgraded to Sell by BidaskClub https://t.co/GMsTVeaLPL
August 13th 2018, 1:08am
TheMarketsDaily @TheMarketsDaily
Adamas Pharmaceuticals $ADMS Raised to “Sell” at BidaskClub https://t.co/onysMgcfCG
August 12th 2018, 2:08pm
OlympiaReport @OlympiaReport
Adamas Pharmaceuticals $ADMS Upgraded to “Sell” at BidaskClub https://t.co/1Fjr9CIjVJ
August 11th 2018, 12:08pm
dispatchtribune @dispatchtribune
Adamas Pharmaceuticals $ADMS Rating Increased to Sell at BidaskClub https://t.co/mBcXKpLT6A
August 11th 2018, 12:08pm
EnterpriseLeade @EnterpriseLeade
Adamas Pharmaceuticals Inc $ADMS Receives $42.63 Average PT from Analysts https://t.co/T8q8xPnSgA
August 11th 2018, 12:08pm
dakotafinancial @dakotafinancial
BidaskClub Upgrades Adamas Pharmaceuticals $ADMS to Sell https://t.co/ovhDDE4qGE
August 10th 2018, 6:08pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2018. All rights reserved.